“Phenotype tells you what a cell is — but 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻 tells you if it has 𝗿𝗲𝗮𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗽𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹.” 💡 In this video, Lightcast Assoc. Dir. of Commercial Development Carrie Maynard explains why functional assays are so important for driving innovation in #DrugDiscovery. #ScienceSky #SingleCell

Antibody-based immunotherapies can target disease with high precision — but #AntibodyDiscovery workflows are slow & costly. Using streamlined functional analysis earlier in the discovery process can help deliver promising therapies quicker, writes our own Jonathan Didier. go.lightcast.bio/47R6ZoF

#AntibodyDiscovery is at a turning point: traditional methods focused on binding rather than function are no longer sufficient. By leveraging droplet #microfluidics our Envisia platform enables deeper analysis of cellular functions. Learn more at our presentation @ the #FestivalofBiologics!

Our Envisia benchtop platform supports a wide range of #SingleCell functional assays — all designed to deepen understanding of cellular heterogeneity & cell-specific behaviours. Find out how you can quickly & more confidently identify promising candidates: go.lightcast.bio/42a4Dxc #Microfluidics

There's a hint of autumn in the air 🍂 , which can only mean one thing: Our team will soon be on the road again! Meet us at an upcoming event to find out more about unlocking deeper #SingleCell insights w/our Envisia benchtop platform. More info on our website: go.lightcast.bio/4n2itKm

Capturing functional readouts like 𝗯𝗶𝗼𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲 𝘀𝗲𝗰𝗿𝗲𝘁𝗶𝗼𝗻, 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗯𝗹𝗼𝗰𝗸𝗶𝗻𝗴 & 𝘁𝗮𝗿𝗴𝗲𝘁 𝗰𝗲𝗹𝗹 𝗸𝗶𝗹𝗹𝗶𝗻𝗴 at the #SingleCell level helps researchers gain a deeper understanding of cell behaviour & therapeutic potential, improving #DrugDiscovery timelines. Learn more: go.lightcast.bio/45WSPAP #ScienceSky 🧪

Our Envisia platform takes a function-focused approach to #AntibodyDiscovery, streamlining the discovery workflow with: 1️⃣ Real-time functional insights 2️⃣ Multi-assay screening 3️⃣ Faster hit identification & single-cell recovery 4️⃣ oEWOD technology to eliminate crosstalk go.lightcast.bio/47w2EH3

Whether we’re developing new workflows, implementing updates to our smart cartridge system, or testing new software features, one thing is clear: success comes from sharing & building on ideas within and across teams. Learn more about what drives our team: lnkd.in/e7gbeBeN #ScienceJobs #ScienceSky

Designed with scientists in mind, our software combines an intuitive user experience with powerful algorithms, enabling analysis of even the most complex functional behaviours. Get results faster, with less time spent learning a new software platform. (1/3) #ScienceSky #AcademicSky #SingleCell

Signal crosstalk between neighbouring cells or reactions can lead to noisy, unreliable data and compromised decision-making. The Envisia platform uses enclosed droplet microenvironments to isolate each cell and its functional assay. (1/3) #SingleCell #ScienceSky #Microfluidics

We're still seeking two commercial development associates to support the commercial expansion of our Envisia benchtop platform in the U.S. and European markets. Learn more and apply: go.lightcast.bio/4lHCKEp #ScienceJobs #ScienceSky 🧪 #Hiring

We're seeking a Commercial Development Associate to help us put our groundbreaking function-focused single-cell analysis technology into the hands of researchers in North America. 📍Boston, US Learn more & apply: go.lightcast.bio/3HTdg8q #ScienceSky #Hiring #ScienceJobs #ResearchJobs #AcademicSky

(1/3) Why does our Envisia platform use droplets? Picolitre-sized droplets are fundamental to isolating individual cells and enabling complex, multi-step assays — without losing biological context or introducing noise from secreted biomolecules. Learn more: go.lightcast.bio/3FZ0zby #microfluidics

Still relying on binding-focused approaches in #AntibodyDiscovery? You could be missing your best functional candidates. Envisia, our next-generation, single-cell platform, was designed to prioritise cellular & antibody functionality from the very start. go.lightcast.bio/4k0KyQa #ScienceSky 🧪

How can our benchtop Envisia platform accelerate #AntibodyDiscovery by bringing key cellular functions — including cytokine secretion, internalisation, and serial killing — into focus? Watch the video to learn more. #ScienceSky 🧪 #AcademicSky #Microfluidics www.youtube.com/watch?v=YctY...

From load to dispense in under 6 hours? Paul Wylie, Lightcast Dir. of Portfolio Management, walks through some of the Envisia #microfluidic platform's key features (like speed!), live from our booth at #PEGS2025. Learn more about Envisia: go.lightcast.bio/42ZdDGx www.youtube.com/watch?v=GjEW...

Last week at #PEGSummit, we were delighted to reveal our Envisia platform to a global audience — and even more thrilled by the interest and engagement we received. Watch the video to see Envisia in action & hear about Lightcast's plans for the future of #SingleCell. www.youtube.com/watch?v=pePx...

Centrally located among biotechs and universities in Kendall Square, our Boston Innovation Center (BIC) manages feasibility studies for our North American customers. 📹 Meet BIC Head Megan Gottlieb and Product Applications Scientist Jassmine Ibea. #ScienceSky 🧪 www.youtube.com/watch?v=57JW...

More about our Envisia benchtop platform: www.lightcast.bio/technology/e... #microfluidics #ScienceSky

#AntibodyDiscovery is often a slow process — especially when multiple functional assays are spread across different instruments in the lab. 👉 Discover how a unified, function-focused platform like Envisia accelerates the discovery process: go.lightcast.bio/43HuFrR #ScienceSky 🧪 #AcademicSky

With the Envisia platform, you can move beyond binding to perform key biochemical and cellular assays like antibody blocking, internalisation, and cytotoxicity — all before a candidate ever leaves the platform. Read our latest white paper: go.lightcast.bio/43HuFrR #ScienceSky 🧪 #AntibodyDiscovery

#JobAlert! Lightcast is hiring Commercial Development Associates in #Boston and #Cambridge (UK). Our ideal candidate has an MSc or PhD in #Biology, #Immunology, or a related field & some experience in the commercial side of biotech. Learn more and apply: www.lightcast.bio/careers #ScienceSky 🧪

Want to join our talented team? Check out open positions on our Careers page: www.lightcast.bio/careers

Recently, a few colleagues shared their artwork inspired by our home city of #Cambridge, featuring quiet moments along the River Cam, the charm of the Waterman pub, and the wisteria-covered buildings that brighten up any walk about town! Thanks to Alfonso, Anna and Greta for sharing their talents!

#JobAlert! Lightcast is hiring Commercial Development Associates in #Boston and #Cambridge (UK). Our ideal candidate has an MSc or PhD in #Biology, #Immunology, or a related field & some experience in the commercial side of biotech. Learn more and apply: www.lightcast.bio/careers #ScienceSky 🧪

With the Envisia platform, you can move beyond binding to perform key biochemical and cellular assays like antibody blocking, internalisation, and cytotoxicity — all before a candidate ever leaves the platform. Read our latest white paper: go.lightcast.bio/43HuFrR #ScienceSky 🧪 #AntibodyDiscovery

#AntibodyDiscovery is often a slow process — especially when multiple functional assays are spread across different instruments in the lab. 👉 Discover how a unified, function-focused platform like Envisia accelerates the discovery process: go.lightcast.bio/43HuFrR #ScienceSky 🧪 #AcademicSky

Centrally located among biotechs and universities in Kendall Square, our Boston Innovation Center (BIC) manages feasibility studies for our North American customers. 📹 Meet BIC Head Megan Gottlieb and Product Applications Scientist Jassmine Ibea. #ScienceSky 🧪 www.youtube.com/watch?v=57JW...

Last week at #PEGSummit, we were delighted to reveal our Envisia platform to a global audience — and even more thrilled by the interest and engagement we received. Watch the video to see Envisia in action & hear about Lightcast's plans for the future of #SingleCell. www.youtube.com/watch?v=pePx...

From load to dispense in under 6 hours? Paul Wylie, Lightcast Dir. of Portfolio Management, walks through some of the Envisia #microfluidic platform's key features (like speed!), live from our booth at #PEGS2025. Learn more about Envisia: go.lightcast.bio/42ZdDGx www.youtube.com/watch?v=GjEW...

In case you missed our reveal yesterday, visit Poster A060 today to learn more about how the Envisia platform can streamline your #AntibodyDiscovery workflows with function-focused #SingleCell analysis. Couldn't make it to #PEGSummit? Learn more about Envisia on our website: lnkd.in/ew-aCSZV

Envisia has arrived. Meet our benchtop #microfluidic platform that captures key #SingleCell functional outputs early in the discovery process by combining advanced instrumentation, a smart cartridge system, and intelligent software. Learn more: go.lightcast.bio/44rBWOp #ScienceSky 🧪 #AcademicSky

We’ve arrived at #PEGSBoston to a beautiful sunset ahead of very exciting event for Lightcast! #PEGSummit

On May 12, we're bringing function into focus. We're unveiling our fully integrated benchtop platform, purpose-built for function-focused #SingleCell analysis. Join our presentation at #PEGSummit to get a first look: Monday, May 12 | 12:40 p.m. #ScienceSky 🧪 #AcademicSky #microfluidics

📣 New white paper 📣 Traditional screening methods often prioritise binding over function, missing critical leads and introducing costly inefficiencies. Learn how Lightcast is redefining #SingleCell screening to accelerate antibody discovery. go.lightcast.bio/3GwRExJ #ScienceSky 🧪 #DrugDiscovery

Such a great way to visualise how far people travel to attend #aacr25!

It’s a beautiful morning here in Chicago as we get ready for #aacr25. Thanks to @theaacr.bsky.social for putting together a fantastic agenda!

Until now, cellular function has largely been inferred from bulk experiments—but understanding cellular behaviours and interactions at the #SingleCell level has remained out of reach. Find out how Lightcast is aiming to change the status quo. www.youtube.com/watch?v=fU3V... #ScienceSky 🧪

How can Lightcast’s function-focused analysis streamline pathways to selecting functional lead candidates? (1/4) Learn more in our white paper: go.lightcast.bio/4ieyUkh #ScienceSky 🧪 #Microfluidics #SingleCell

The Boston Innovation Center (BIC) BIC plays a key role in supporting the Lightcast Luminary Programme, which gives early-access customers the opportunity to apply Lightcast technology to their customised protocols and workflows. (1/3) www.youtube.com/watch?v=kFqJ... #ScienceSky 🧪 #biotech

How can the Lightcast platform streamline #DrugDiscovery workflows with a function-focused approach to #SingleCell analysis? Find out in San Diego, Chicago, or Boston this spring! Drop by our booth or schedule a chat with our team here: www.lightcast.bio/news-and-eve... #ScienceSky 🧪 #AcademicSky

The ultimate goal of #AntibodyDiscovery is to develop therapeutics that not only bind to a target but also exert a meaningful biological effect. However, traditional methods often prioritise binding affinity over function. #ScienceSky 🧪 #Lightcast Read our white paper: go.lightcast.bio/4ieyUkh

A function-focused approach to #SingleCellAnalysis recognizes that all therapies—whether cell therapy, checkpoint inhibitors, therapeutic antibodies, or ADCs—are fundamentally rooted in the modulation of cellular functions to achieve therapeutic outcomes. (1/3) #ScienceSky #AcademicSky 🧪

A function-focused approach to #SingleCell screening offers direct insights that reduce the need for time-consuming follow-up screens and enable faster, more precise drug discovery. (1/6) #ScienceSky 🧪

We're happy to be back at #NextGenBiomed in London this week! If you missed us today, we'll be waiting for you at Booth 62 tomorrow. #ScienceSky #biotech #microfluidics

Will we see you at #NextGenBiomed in London this week? Drop by Booth 62 to learn how Lightcast can streamline discovery workflows by enabling precise interrogation of #singlecell interactions and functional behaviours at scale. #ScienceSky 🧪 #microfluidics

Last week, we introduced one of our Luminary early-access partners: the Tech Watch team at VIB (@vibtechnologies.bsky.social)! In this video, Technology Expert Sarah Geurs tells us about the team's work, and about what drew her to join Tech Watch. www.youtube.com/watch?v=l-4J... #ScienceSky 🧪

With typical droplet-based technologies, nearly three in four droplets may be rendered unusable, wasting researchers' most valuable resources: time and cells. (1/7) #Lightcast #ScienceSky 🧪 #microfluidics

We're happy to introduce VIB Tech Watch (@vibtechnologies.bsky.social) as one of our Luminary early-access partners. Our work with EAPs allows us to continuously improve the Lightcast platform & empower researchers to better understand cellular function. #ScienceSky 🧪 youtu.be/3pfyDmHKnmI?...

The tumour microenvironment is a complex landscape, where diverse immune cells and tumour interactions influence treatment outcomes. (1/5) #ScienceSky 🧪 #cancer #drugdiscovery www.youtube.com/watch?v=wxz5...